Afrezza revenue rose 23% to $18.49 million in the three months through the end of September, owing to higher prices and ...

MannKind (MNKD) stock jumps after Q3 2025 results beat forecasts, driven by Afrezza growth and strong cash position. Read more here.

This article first appeared on GuruFocus. MannKind Corp (NASDAQ:MNKD) is set to release its Q3 2025 earnings on Nov 5, 2025.

MannKind (MNKD) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of $0.01 per share. This compares to earnings of $0.04 per share a year ago. These figures are ...

The Danbury, Connecticut-based company said it had profit of 3 cents per share. The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...

We can see that MannKind does have institutional investors; and they hold a good portion of the company's stock. This can indicate that the company has a certain degree of credibility in the ...

MannKind Corporation faces significant risks due to international trade policies, which could adversely impact its business and financial condition. The company’s reliance on a global supply chain for ...

Q3 2025 Earnings Call November 5, 2025 9:00 AM ESTCompany ParticipantsMichael Castagna - CEO & DirectorChristopher ...

Q3 2025 revenues of $82.1M, +17% v. Q3 2024YTD 2025 revenues of $237.0M, +14% v. YTD 2024Completed acquisition of scPharmaceuticals on October 7, ...